# Plasmafit® Revision Structan® Hip Endoprosthesis Cup

> **NCT04255966** · — · ACTIVE_NOT_RECRUITING · sponsor: **Aesculap AG** · enrollment: 60 (actual)

## Conditions studied

- Osteolysis
- Arthroplasty Complications
- Instability of Prosthetic Joint
- Degenerative Osteoarthritis
- Rheumatic Arthritis
- Fractures, Hip
- Femoral Head Avascular Necrosis
- Prosthesis Failure

## Interventions

- **DEVICE:** Plasmafit® Revision Structan®

## Key facts

- **NCT ID:** NCT04255966
- **Lead sponsor:** Aesculap AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-12
- **Primary completion:** 2023-08-16
- **Final completion:** 2027-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04255966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04255966, "Plasmafit® Revision Structan® Hip Endoprosthesis Cup". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04255966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*